Annual Total Long Term Liabilities
$15.90 M
-$9.81 M-38.17%
December 31, 2023
Summary
- As of February 7, 2025, ABUS annual total long term liabilities is $15.90 million, with the most recent change of -$9.81 million (-38.17%) on December 31, 2023.
- During the last 3 years, ABUS annual total long term liabilities has fallen by -$9.68 million (-37.84%).
- ABUS annual total long term liabilities is now -89.68% below its all-time high of $154.03 million, reached on December 31, 2015.
Performance
ABUS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$14.63 M
-$366.00 K-2.44%
September 30, 2024
Summary
- As of February 7, 2025, ABUS quarterly total long term liabilities is $14.63 million, with the most recent change of -$366.00 thousand (-2.44%) on September 30, 2024.
- Over the past year, ABUS quarterly long term liabilities has dropped by -$729.00 thousand (-4.75%).
- ABUS quarterly long term liabilities is now -91.35% below its all-time high of $169.19 million, reached on June 30, 2015.
Performance
ABUS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ABUS Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.2% | -4.8% |
| 3 y3 years | -37.8% | -43.1% |
| 5 y5 years | -3.3% | -43.1% |
ABUS Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.2% | at low | -62.1% | at low |
| 5 y | 5-year | -38.2% | at low | -62.1% | at low |
| alltime | all time | -89.7% | -100.0% | -91.3% | -100.0% |
Arbutus Biopharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $14.63 M(-2.4%) |
| Jun 2024 | - | $14.99 M(-2.4%) |
| Mar 2024 | - | $15.36 M(-3.4%) |
| Dec 2023 | $15.90 M(-38.2%) | $15.90 M(-6.4%) |
| Sep 2023 | - | $16.98 M(-3.5%) |
| Jun 2023 | - | $17.60 M(-20.6%) |
| Mar 2023 | - | $22.16 M(-13.8%) |
| Dec 2022 | $25.71 M(+7.9%) | $25.71 M(-16.5%) |
| Sep 2022 | - | $30.78 M(-6.4%) |
| Jun 2022 | - | $32.87 M(-14.9%) |
| Mar 2022 | - | $38.62 M(+62.1%) |
| Dec 2021 | $23.82 M(-6.8%) | $23.82 M(-6.0%) |
| Sep 2021 | - | $25.34 M(-1.4%) |
| Jun 2021 | - | $25.71 M(+1.2%) |
| Mar 2021 | - | $25.40 M(-0.7%) |
| Dec 2020 | $25.57 M(+2.4%) | $25.57 M(-2.2%) |
| Sep 2020 | - | $26.15 M(+1.4%) |
| Jun 2020 | - | $25.79 M(+1.8%) |
| Mar 2020 | - | $25.33 M(+1.5%) |
| Dec 2019 | $24.96 M(+51.9%) | $24.96 M(+0.6%) |
| Sep 2019 | - | $24.82 M(+28.6%) |
| Jun 2019 | - | $19.30 M(+0.6%) |
| Mar 2019 | - | $19.18 M(+16.7%) |
| Dec 2018 | $16.43 M(-59.0%) | $16.43 M(-6.0%) |
| Sep 2018 | - | $17.48 M(-36.2%) |
| Jun 2018 | - | $27.40 M(+0.7%) |
| Mar 2018 | - | $27.21 M(-32.1%) |
| Dec 2017 | $40.06 M(-35.7%) | $40.06 M(-37.6%) |
| Sep 2017 | - | $64.22 M(-4.7%) |
| Jun 2017 | - | $67.41 M(-1.1%) |
| Mar 2017 | - | $68.17 M(+9.4%) |
| Dec 2016 | $62.33 M(-59.5%) | $62.33 M(-30.5%) |
| Sep 2016 | - | $89.71 M(+0.3%) |
| Jun 2016 | - | $89.45 M(-41.9%) |
| Mar 2016 | - | $154.06 M(+0.0%) |
| Dec 2015 | $154.03 M | $154.03 M(-0.6%) |
| Sep 2015 | - | $154.99 M(-8.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $169.19 M(+0.4%) |
| Mar 2015 | - | $168.50 M(+1595.7%) |
| Dec 2014 | $9.94 M(>+9900.0%) | $9.94 M(-1.4%) |
| Sep 2014 | - | $10.07 M(-4.1%) |
| Jun 2014 | - | $10.51 M(+5.1%) |
| Mar 2014 | - | $10.00 M(>+9900.0%) |
| Dec 2013 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(-100.0%) |
| Mar 2013 | - | $309.60 K(-57.1%) |
| Dec 2012 | $722.40 K(-56.4%) | $722.40 K(-30.8%) |
| Sep 2012 | - | $1.04 M(-17.7%) |
| Jun 2012 | - | $1.27 M(-17.0%) |
| Mar 2012 | - | $1.53 M(-7.6%) |
| Dec 2011 | $1.66 M(-23.2%) | $1.66 M(-8.3%) |
| Sep 2011 | - | $1.81 M(-16.2%) |
| Jun 2011 | - | $2.15 M(-1.0%) |
| Mar 2011 | - | $2.17 M(+0.9%) |
| Dec 2010 | $2.16 M(>+9900.0%) | $2.16 M(>+9900.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2008 | - | $65.40 K(-94.4%) |
| Sep 2007 | - | $1.17 M(-46.5%) |
| Jun 2007 | - | $2.19 M |
| Dec 2006 | $65.00 K(-99.8%) | - |
| Dec 2005 | $34.78 M(-14.3%) | - |
| Dec 2004 | $40.59 M(+30.3%) | - |
| Dec 2003 | $31.14 M(+871.6%) | - |
| Dec 2001 | $3.21 M(+430.0%) | - |
| Dec 2000 | $604.80 K(-10.3%) | - |
| Dec 1999 | $674.00 K(+17.3%) | - |
| Dec 1998 | $574.50 K | - |
FAQ
- What is Arbutus Biopharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for Arbutus Biopharma?
- What is Arbutus Biopharma annual total long term liabilities year-on-year change?
- What is Arbutus Biopharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Arbutus Biopharma?
- What is Arbutus Biopharma quarterly long term liabilities year-on-year change?
What is Arbutus Biopharma annual total long term liabilities?
The current annual total long term liabilities of ABUS is $15.90 M
What is the all time high annual total long term liabilities for Arbutus Biopharma?
Arbutus Biopharma all-time high annual total long term liabilities is $154.03 M
What is Arbutus Biopharma annual total long term liabilities year-on-year change?
Over the past year, ABUS annual total long term liabilities has changed by -$9.81 M (-38.17%)
What is Arbutus Biopharma quarterly total long term liabilities?
The current quarterly long term liabilities of ABUS is $14.63 M
What is the all time high quarterly long term liabilities for Arbutus Biopharma?
Arbutus Biopharma all-time high quarterly total long term liabilities is $169.19 M
What is Arbutus Biopharma quarterly long term liabilities year-on-year change?
Over the past year, ABUS quarterly total long term liabilities has changed by -$729.00 K (-4.75%)